Clinical and Cost Effectiveness of Telerehabilitation System in Balance Disorder Patients

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F24%3A00369075" target="_blank" >RIV/68407700:21460/24:00369075 - isvavai.cz</a>

Výsledek na webu

<a href="https://doi.org/10.1007/978-3-031-42775-6_50" target="_blank" >https://doi.org/10.1007/978-3-031-42775-6_50</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/978-3-031-42775-6_50" target="_blank" >10.1007/978-3-031-42775-6_50</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Clinical and Cost Effectiveness of Telerehabilitation System in Balance Disorder Patients

Popis výsledku v původním jazyce

Balance disorders are a very common consequence of brain damage. Most of these conditions have a chronic nature and require long-term rehabilitation care. Telerehabilitation using the Homebalance system is a suitable alternative or complement to standard rehabilitation. The aim of this study is to evaluate the clinical and cost effectiveness of the Homebalance system in telerehabilitation. The study involved 33 patients who were randomly divided into two groups. The intervention group underwent a 4-week telerehabilitation therapy using the Homebalance system. The comparison group received standard in-person rehabilitation care of the same length. Clinical effectiveness was assessed using the standardized Berg Balance scale test. Quality of life was measured using the EQ-5D-5L questionnaire. The cost part of the study was evaluated from a healthcare payer perspective. Clinical effectiveness of the telerehabilitation was demonstrated by difference in the pre-post BBS scores (p < 0,001), which was comparable to the effectiveness of standard therapy (p = 0,52). No significant changes were observed in the patient’s quality of life during the therapy. The costs of the experimental intervention were estimated at CZK 7,152, while the costs of the comparator were estimated at CZK 9,424. Telerehabilitation brings many benefits for patients allowing to undergo therapy from the comfort of their homes. The results of this study have shown that telerehabilitation using the Homebalance system is clinically effective, and also cost-effective.

Název v anglickém jazyce

Clinical and Cost Effectiveness of Telerehabilitation System in Balance Disorder Patients

Popis výsledku anglicky

Balance disorders are a very common consequence of brain damage. Most of these conditions have a chronic nature and require long-term rehabilitation care. Telerehabilitation using the Homebalance system is a suitable alternative or complement to standard rehabilitation. The aim of this study is to evaluate the clinical and cost effectiveness of the Homebalance system in telerehabilitation. The study involved 33 patients who were randomly divided into two groups. The intervention group underwent a 4-week telerehabilitation therapy using the Homebalance system. The comparison group received standard in-person rehabilitation care of the same length. Clinical effectiveness was assessed using the standardized Berg Balance scale test. Quality of life was measured using the EQ-5D-5L questionnaire. The cost part of the study was evaluated from a healthcare payer perspective. Clinical effectiveness of the telerehabilitation was demonstrated by difference in the pre-post BBS scores (p < 0,001), which was comparable to the effectiveness of standard therapy (p = 0,52). No significant changes were observed in the patient’s quality of life during the therapy. The costs of the experimental intervention were estimated at CZK 7,152, while the costs of the comparator were estimated at CZK 9,424. Telerehabilitation brings many benefits for patients allowing to undergo therapy from the comfort of their homes. The results of this study have shown that telerehabilitation using the Homebalance system is clinically effective, and also cost-effective.

Druh

D - Stať ve sborníku

CEP obor

—

OECD FORD obor

20601 - Medical engineering

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2024

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

6th International Conference on Nanotechnologies and Biomedical Engineering

ISBN

978-3-031-42781-7

ISSN

1680-0737

e-ISSN

1433-9277

Počet stran výsledku

9

Strana od-do

467-475

Název nakladatele

Springer Nature Switzerland AG

Místo vydání

Basel

Místo konání akce

Kišiněv

Datum konání akce

20. 9. 2023

Typ akce podle státní příslušnosti

WRD - Celosvětová akce

Kód UT WoS článku

—